智慧胰島素筆市場按適應症、性別、分銷管道和地區分類

Smart Insulin Pen Market, By Indication, By Connectivity, By Distribution Channel, and by Region

出版日期: 2025年07月28日 | 出版商:

Coherent Market Insights | 英文 105 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

智慧胰島素筆市場規模預計在 2025 年達到 5,450 萬美元，預計到 2032 年將達到 1.153 億美元，2025 年至 2032 年的複合年成長率為 11.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	5450萬美元
效能數據	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	11.30%	2032年價值預測	1.153億美元

智慧胰島素筆是可重複使用的注射器筆，配有直覺的智慧型手機應用程式，可幫助糖尿病患者更好地管理胰島素劑量。這些智慧型系統可以計算和追蹤劑量，並提供實用的提醒、警報和報告。它們可以作為您現有胰島素筆的附加組件，也可以作為使用預填充藥筒（而非管瓶或一次性胰島素筆）的可重複使用設備。第一批胰島素筆於 20 世紀 80 年代末期推出，作為管瓶和注射器的替代品，可以更精確地給藥、更好地堅持用藥並減少注射部位的疼痛。隨著這些設備的發展，它們配備了數位顯示器並開始儲存最新的胰島素劑量。最終，數據追蹤附件的開發，使拋棄式胰島素筆能夠更好地追蹤劑量。隨後，血糖感測、持續血糖監測、給藥定時、提醒和其他功能也得到了發展。美國食品藥物管理局(FDA) 批准的第一款可重複使用的智慧胰島素筆於 2017 年發布。智慧筆的設計易於使用。只需將應用程式下載到您的智慧型手機，並將其與胰島素筆配對，即可開始使用。該設備透過藍牙連接將即時數據發送到應用程式。

市場動態

全球糖尿病盛行率的不斷上升、主要市場參與者採取的收購併購等成長策略、新型胰島素產品的推出以及研發活動的不斷開展，正在推動全球智慧胰島素筆市場的成長。例如，2020年8月12日，美國醫療服務公司美敦力宣布計畫收購美國醫療醫療設備。 Companion Medical是InPen的製造商，InPen是一款經美國食品藥物管理局批准的智慧胰島素筆系統，並配備整合的糖尿病管理應用程式。

本次調查的主要特點

本報告對全球智慧胰島素筆市場進行了詳細分析，並以 2024 年為基準年，提供了預測期 2025-2032 的市場規模（百萬美元）和年複合成長率(CAGR)。
它揭示了不同領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球智慧胰島素筆市場的主要企業。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球智慧胰島素筆市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球智慧胰島素筆市場的各種策略矩陣更輕鬆地做出決策。

Digital Medics Pty. Ltd.
Emperra GmbH E-Health Technologies
Novo Nordisk
Companion Medical Inc.
Jiangsu Deflu Medical Device Co. Ltd.
Medtronic PLC
Pendiq GmbH
Sanofi
Berlin Chemie Companion Medical Inc.
Bigfoot Biomedical
Digital Medics Pty Ltd
Eli Lilly and company
Ypsomed Holding AG
Diabnext Diamesco Co. Ltd.

第9章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI3436

Smart Insulin Pen Market is estimated to be valued at USD 54.5 Mn in 2025 and is expected to reach USD 115.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 54.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.30%	2032 Value Projection:	USD 115.3 Mn

A smart insulin pen is a reusable injector pen with an intuitive smartphone app that can help people with diabetes better manage insulin delivery. This smart system calculates and tracks doses and provides helpful reminders, alerts, and reports. They can come in the form of an add-on to current insulin pen or a reusable form which uses prefilled cartridges instead of vials or disposable pens. The first insulin pen devices were introduced in the late 1980s as an alternative to vials and syringes. They allowed for more accurate dosing, better adherence, and less injection site pain. As these devices evolved, they gained digital displays and memory of the most recent insulin doses. Eventually, data tracking attachments were developed to help disposable insulin pens keep better track of doses. Glucose sensing, continuous glucose monitoring, dosage timing, reminders, and other advancements followed. The first U.S. Food and Drug Administration (FDA)-cleared reusable smart insulin pen was launched in 2017. Smart pens are designed to be simple to use. Once the app is downloaded to smartphone and paired it with insulin pen, it is ready to go. The device sends real-time data to the app via Bluetooth connection.

Market Dynamics

Increasing prevalence of diabetes worldwide, adoption of growth strategies such as acquisitions and mergers from key market players, introduction of newer insulin products and research and development activities are driving the growth of global smart insulin pen market. For instance, in August 12, 2020, Medtronics, a U.S.-based medical service company, announced the planned acquisition of Companion Medical, a U.S.-based medical devices manufacturer, who is a manufacturer of InPen- a U.S. Food and Drug Administration cleared smart insulin pen system paired with an integrated diabetes management app.

Key features of the study

This report provides an in-depth analysis of the global smart insulin pen market and provides market size (USD Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global smart insulin pen market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk, Companion Medical Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Pendiq GmbH, Sanofi, Berlin Chemie Companion Medical Inc., Bigfoot Biomedical, Digital Medics Pty ltd, Eli Lilly and company, Ypsomed Holding AG, Diabnext Diamesco Co. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global smart insulin pen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart insulin pen market.

Market Segmentation

Global Smart Insulin Pen Market, By Indication
- Type 1 Diabetes
- Type 2 Diabetes
Global Smart Insulin Pen Market, By Connectivity
- Bluetooth
- USB
Global Smart Insulin Pen Market, By Distribution Channel
- Clinics and Ambulatory Surgical Centers
- e-Commerce
- Retail Pharmacies
Global Smart Insulin Pen Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Digital Medics Pty. Ltd.
- Emperra GmbH E-Health Technologies
- Novo Nordisk
- Companion Medical Inc.
- Jiangsu Deflu Medical Device Co. Ltd.
- Medtronic PLC
- Pendiq GmbH
- Sanofi
- Berlin Chemie Companion Medical Inc.
- Bigfoot Biomedical
- Digital Medics Pty Ltd.
- Eli Lilly and company
- Ypsomed Holding AG
- Diabnext Diamesco Co. Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Indication
- Market Snapshot, By Connectivity
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Smart Insulin Pen Market, By Indication, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)

5. Global Smart Insulin Pen Market, By Connectivity, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Bluetooth
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
USB
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)

6. Global Smart Insulin Pen Market, By Distribution Channel, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Clinics and Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
e-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)

7. Global Smart Insulin Pen Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Digital Medics Pty. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Emperra GmbH E-Health Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novo Nordisk
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Companion Medical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Jiangsu Deflu Medical Device Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pendiq GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Berlin Chemie Companion Medical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bigfoot Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Digital Medics Pty Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ypsomed Holding AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Diabnext Diamesco Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies